Cover image of the article: Epidermal Growth Factor Receptor Gene in Prostate Cancer after Radical Prostatectomy

Image Credit:Int J Cancer Manag

Epidermal Growth Factor Receptor Gene in Prostate Cancer after Radical Prostatectomy

Authors

Bahram Mofid1,*, MR Jalali Nadoushan2, A Rakhsha1, HR Mirzaei1, L Zeinali1
1Dep. of Oncology, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Dep. of Pathology, Shahed University, Tehran, Iran
*Corresponding Author: Corresponding author: Bahram Mofid, Dep. of Oncology, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tel: +98-2122724090, E-mail: Email: mofid429@yahoo.com

International Journal of Cancer Management:Vol. 3, issue 4; e80713
Published online:Dec 31, 2010
Article type:Research Article
Received:Jul 06, 2010
Accepted:Sep 20, 2010
How to Cite:Mofid B, Jalali Nadoushan M, Rakhsha A, Mirzaei H, Zeinali L. Epidermal Growth Factor Receptor Gene in Prostate Cancer after Radical Prostatectomy. Int J Cancer Manag. 2010;3(4):e80713. doi:

Abstract

Background: The aim of this study was to evaluate over expression of epidermal growth factor receptor (EGFR) gene in localized prostate cancers and determine its relation with clinical and pathological factors affecting the progression of the disease.

Methods: In the tissue samples of the patients with prostate cancer undergoing radical prostatectomy, EGFR expression was evaluated by immunohistochemistry technique. Those with scores 2 and 3 were considered to be positive for the expression. The relation between gene expression and grade was evaluated by chi-square test. Results: Of 100 tissue samples evaluated, 80 and 20 had Gleason score (GS) < 7 and ≥ 7, respectively. Also, 68 and 32 had PSA level ≤ 10 and >10, respectively. A total of 59 samples were positive for EGFR expression, of whom, 46 had GS < 7 and 13 had GS > 7 (P-value = 0.39). Forty patients had PSA < 10 and 19 had PSA > 10 (P-value = 0.5). Conclusion: Fifty-nine percent of the patients with localized prostate cancer undergoing radical prostatectomy were EGFR positive. No significant relation was found between EGFR and grading (GS) or PSA.

Highlights

Fulltext

Full text is available in PDF.

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

23
Feb
2016
Evaluating the Prevalence of the Epidermal Growth Factor Receptor in Transitional Cell Carcinoma of Bladder and its Relationship With Other Prognostic Factors

Evaluating the Prevalence of the Epidermal Growth Factor Receptor in Transitional Cell Carcinoma of Bladder and its Relationship With Other Prognostic Factors

Mahmoud Parvin,
Parto Sabet-Rasekh,
Parastoo Hajian,
Peyman Mohammadi Torbati,
Parisa Sabet-Rasekh,
Hamidreza Mirzaei

Parvin M, Sabet-Rasekh P, Hajian P, Mohammadi Torbati P, Sabet-Rasekh P, et al. Evaluating the Prevalence of the Epidermal Growth Factor Receptor in Transitional Cell Carcinoma of Bladder and its Relationship With Other Prognostic Factors. Int J Cancer Manag. 2016;9(1):e4022. doi: https://doi.org/10.17795/ijcp-4022

5
Aug
2023
The Value of Epidermal Growth Factor Receptor Expression in Predicting Aggressive Behaviors of Bladder Neoplasms

The Value of Epidermal Growth Factor Receptor Expression in Predicting Aggressive Behaviors of Bladder Neoplasms

Seyed Amir Miratashi Yazdi,
Farnoosh Asghari,
Hedieh Moradi Tabriz,
Behnoud Vesali,
Elham Nazar

Miratashi Yazdi SA, Asghari F, Moradi Tabriz H, Vesali B, Nazar E. The Value of Epidermal Growth Factor Receptor Expression in Predicting Aggressive Behaviors of Bladder Neoplasms. Nephro-Urol Mon. 2023;15(2):e137778. doi: https://doi.org/10.5812/numonthly-137778

27
Apr
2014
Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies

Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies

Mohammad Reza Sharif,
Amirreza Shaabani,
Hossein Mahmoudi,
Hassan Nikoueinejad,
Hossein Akbari,
Behzad Einollahi

Sharif MR, Shaabani A, Mahmoudi H, Nikoueinejad H, Akbari H, et al. Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies. Nephro-Urol Mon. 2014;6(3):e14778. doi: https://doi.org/10.5812/numonthly.14778

17
Sep
2018
Prevalence of the Vascular Endothelial Growth Factor Receptor (VEGER) in Transitional Cell Carcinoma (TCC) of Bladder and its Relationship with Other Prognostic Factors

Prevalence of the Vascular Endothelial Growth Factor Receptor (VEGER) in Transitional Cell Carcinoma (TCC) of Bladder and its Relationship with Other Prognostic Factors

Hamidreza Mirzaei,
Parisa Sabetrasekh,
Parto Sabetrasekh,
Mahmoud Parvin,
Peyman Torbati,
Parastoo Hajian

Mirzaei H, Sabetrasekh P, Sabetrasekh P, Parvin M, Torbati P, et al. Prevalence of the Vascular Endothelial Growth Factor Receptor (VEGER) in Transitional Cell Carcinoma (TCC) of Bladder and its Relationship with Other Prognostic Factors. Int J Cancer Manag. 2018;11(9):e66188. doi: https://doi.org/10.5812/ijcm.66188

18
Feb
2022
Association of STAT3, PTPRT, TNK2-AS1, LINC-ROR Genes Expression Level with Prostate Cancer and Benign Prostatic Hyperplasia

Association of STAT3, PTPRT, TNK2-AS1, LINC-ROR Genes Expression Level with Prostate Cancer and Benign Prostatic Hyperplasia

Maryam Ahani,
Sayyed Mohammad Hossein Ghaderian,
Mitra Mehr Azma,
Koosha Kamali,
Bahar Naghavi Gargari,
Samaneh Vojdani

Ahani M, Ghaderian SMH, Mehr Azma M, Kamali K, Naghavi Gargari B, et al. Association of STAT3, PTPRT, TNK2-AS1, LINC-ROR Genes Expression Level with Prostate Cancer and Benign Prostatic Hyperplasia. Int J Cancer Manag. 2022;15(1):e120188. doi: https://doi.org/10.5812/ijcm.120188

More by these authors

Bahram MofidPubMedScholar
MR Jalali NadoushanPubMedScholar
A RakhshaPubMedScholar
HR MirzaeiPubMedScholar
L ZeinaliPubMedScholar
Share
Cited by
Metrics